A Strange Pressure Headache: When a Sinusitis Diagnosis Hid a Fatal Brain Tumor

MJ was a 38-year-old physician who walked into her own hospital's emergency room with an ordinary complaint: a week of fullness around her eyes and nose, a constant bilateral pain radiating to her forehead, and ears that popped whenever she yawned or pinched her nose to equalize pressure. Painkillers softened it, then it returned unchanged once they wore off. It resembled a cold, but to her it felt like something different.

Her colleague found bilateral middle ear effusion on exam, meaning fluid collected in both ears. Her nasal lining was red and swollen, and the ear-nose findings explained the headache. Because the sinuses sit beside the cranial nerves running from the brain to the face, the doctor also tested eye, nose, and tongue movements; all were normal. The verdict was acute sinusitis, and MJ went home with antibiotics.

When the antibiotics failed

Two days later MJ woke up with blurry vision, and as the day wore on the picture sharpened into double vision . Extending her neck forward sent a sensation rushing into her forehead, as if an ice pick were being driven between her eyes. Her primary care doctor repeated the exam, saw the same mild ear-nose swelling with normal nerve function, but the symptoms had now progressed on antibiotics. A small steroid dose was prescribed, and the ear-nose-throat referral could only be scheduled 11 days out.

At the ENT office a camera sent up her nose revealed hypertrophy in the lower left nasal cavity; MJ had struggled to breathe through that side for years. The back wall of her throat was red with a cobblestone appearance, a sign her immune system was reacting to something in her sinuses. Her eye exam was normal that day, there was no fever, and the picture still fit acute sinusitis. A second, 12-day antibiotic course began, but it would never be finished.

Speed is everything: the differential logic

Six days later her symptoms felt as if they were pushing out of her skull, and MJ walked through the reasoning again with her first doctor. A hyperacute headache arriving in seconds would suggest a vascular event, but hers was a subacute picture unfolding over days. Toxic causes such as carbon monoxide would alter consciousness, which never happened; autoimmunity blood tests were negative; bacteria would have taken her down far quicker than three weeks. What remained was the most feared possibility: a brain tumor growing and squeezing inside the skull.

The numbers argued against the tumor, not for it. Intracranial tumors strike 1 to 5 people per 100,000 and usually past age 45, while sinusitis hits 15,000 per 100,000, making it 3,000 to 15,000 times more likely in her case. So the tumor went into the notes as a distant possibility, never explicitly ruled out. But symptoms were worsening and antibiotics were doing nothing; MJ wanted the top of the list eliminated and the tumor genuinely crossed off. The way to look directly was a head CT, and the scan was scheduled for first thing the next morning.

The scheduled scan and a silent week

That evening MJ went home and sat down to dinner; her vision doubled again, she leaned her head forward, and a sudden thunderclap headache struck, then it was over. She never showed up for the morning CT and answered no calls or texts for seven days. Her mother called the police, and the hospital where she practiced started searching for its missing doctor. Officers broke down her door to find MJ slumped on the couch, the television on, dinner on the table; she had been gone for days.

Autopsy: a mass from the third ventricle

The forensic exam found no trauma and clean toxicology. Once the skull was opened and coronal slices were cut, the pathologists hit something that was not normal brain: a two-inch, roughly 5-centimeter tumor, necrotic and bleeding, growing out of the midline third ventricle, infiltrating the thalamus and reaching down to the fourth ventricle. According to an MDPI review of high-grade thalamic gliomas, tumors in this location are especially prone to blocking cerebrospinal fluid pathways and crushing nearby structures, which explains the pressure signs in MJ's course.

The mechanism starts with the skull's rigidity: a growing mass first bends the brain, then CSF flow gets blocked and intracranial pressure shoots up, so headaches come and go as pressure surges and settles. Because the tumor extended into the midbrain, the oculomotor, trochlear, and abducens nerves plus the optic chiasm came under pressure, which explains why double vision appeared on some days and vanished on others. Neither the headache nor the visual failure was coincidence; both were two faces of the same compression.

The microscope completed the picture: the mass came not from nerve cells but from supportive glia ; cells divided abnormally, the tumor grew its own blood vessels to keep feeding itself, and dying cancer cells rotted into healthy tissue, destroying critical structures. The brainstem, made of midbrain, pons, and medulla, governs the heart and breathing; the mass either rotted this region directly or raised pressure so high that cardiopulmonary control collapsed. According to SEOM-GEINO guidelines published by Springer, high-grade gliomas are the most common malignant primary brain tumors, and survival with this genotype is unfortunately measured in months.

Why sinusitis looked so convincing

The most instructive part in hindsight is why sinusitis was confirmed at three separate exams. MJ lacked the usual company of acute sinusitis: respiratory infection signs appear in 80 percent of cases and runny nose in 78 percent, yet she had only pain and congestion. According to an emergency-department study published by Frontiersin, more than 12 percent of headache patients get a cranial CT, and these scans contribute to the diagnosis only about 2 percent of the time; chasing the rare finding in every patient is simply not a sustainable strategy.

The case unfolded between late 2024 and early 2025, and the story connects here to the yearly whole-body MRI debate. This fast-growing glioma might not even have shown on a scan the previous spring; and even if it had, imaging shows that something is there without saying what it is. Midline brain surgery carries risks of permanent disfigurement and brain damage, so whether to operate on an early ambiguous mass or watch it over days and weeks is a dilemma in itself. According to a selective MRI screening critique published by JAMANetwork, elective screening of the general population is a promise open to fear-based marketing, and buyers should stay cautious.

The autopsy's final page concerned her heart and had nothing to do with the tumor. Between MJ's two atria sat a 1-centimeter benign growth; it causes no symptoms and never spreads, a pure incidental finding. The real silent threat was an 80 percent blockage in the artery feeding the most muscular part of her heart, a severe picture for a 38-year-old and a warning of an approaching heart attack. According to research published by BMJ in Open Heart, mixed plaque found on coronary CT in asymptomatic intermediate-risk people predicts long-term cardiac events, showing the screenable face of silent vessel disease. According to a 2026 RSNA assessment, whole-body MRI programs make sense when led by radiologists for the right target population, not as a blanket shield for everyone. Racing the odds on the CDC lightning FAQ page, the narrator equates sudden death from an unknown tumor with a lightning strike at best; the unheard-of is not more common than thought, it is simply unheard.